[Seite 85↓]

6. References

(2002): Breakthrough of the year. Scorecard 2002, Science 298 [5602], Page 2299.

Abate-Shen, C. und Shen, M. M. (2000): Molecular genetics of prostate cancer, Genes Dev. 14 [19], Page 2410-2434.

Abrahamsson, P. A. (1996): Neuroendocrine differentiation and hormone-refractory prostate cancer, Prostate Suppl 6, Page 3-8.

Akusjarvi, G. und Stevenin, J. (2003): Remodelling of the host cell RNA splicing machinery during an adenovirus infection, Curr.Top.Microbiol.Immunol. 272, Page 253-286.

Amiri, H.; Schultz, G. und Schaefer, M. (2003): FRET-based analysis of TRPC subunit stoichiometry, Cell Calcium 33 [5-6], Page 463-470.

Augustus, M., Davis, L., Lawrence, T., Schroeck, E., Heselmeyer-Haddad, K., McLeod, D. G., Mostofi, F. K., Carter, K. C., Sesterhenn, I. A., Moul, J. W., Srivastava, S., and Ried, T. : Characterization of CPDR-1, a new primary prostate cell line: A comparison with metastatic prostate cancer cell lines LNCaP, PC3 and DU 145 by Spectral karyotyping (SKY). URL: http://www.cpdr.org/abstracts/meena/imageslegends.shtml

Bakowski, D. und Parekh, A. B. (2002): Permeation through store-operated CRAC channels in divalent-free solution: potential problems and implications for putative CRAC channel genes, Cell Calcium 32 [5-6], Page 379-391.

Bentel, J. M. und Tilley, W. D. (1996): Androgen receptors in prostate cancer, J.Endocrinol. 151 [1], Page 1-11.

Berget, S. M.; Moore, C. und Sharp, P. A. (1977): Spliced segments at the 5' terminus of adenovirus 2 late mRNA, Proc.Natl.Acad.Sci.U.S.A 74 [8], Page 3171-3175.

Boise, L. H.; Gonzalez-Garcia, M.; Postema, C. E.; Ding, L.; Lindsten, T.; Turka, L. A.; Mao, X.; Nunez, G. und Thompson, C. B. (1993): bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell 74 [4], Page 597-608.

Bonfield, J. K.; Smith, K. und Staden, R. (1995): A new DNA sequence assembly program, Nucleic Acids Res. 23 [24], Page 4992-4999.

Bostwick, D. G.; Qian, J.; Pacelli, A.; Zincke, H.; Blute, M.; Bergstralh, E. J.; Slezak, J. M. und Cheng, L. (2002): Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival, J.Urol. 168 [3], Page 1204-1211.

Bova, G. S.; Carter, B. S.; Bussemakers, M. J.; Emi, M.; Fujiwara, Y.; Kyprianou, N.; Jacobs, S. C.; Robinson, J. C.; Epstein, J. I.; Walsh, P. C. und . (1993): Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer, Cancer Res. 53 [17], Page 3869-3873.

Bova, G. S. und Isaacs, W. B. (1996): Review of allelic loss and gain in prostate cancer, World J.Urol. 14 [5], Page 338-346.

Caplan, A. und Kratz, A. (2002): Prostate-specific antigen and the early diagnosis of prostate cancer, Am.J.Clin.Pathol. 117 Suppl, Page S104-S108.

Carter, B. S.; Beaty, T. H.; Steinberg, G. D.; Childs, B. und Walsh, P. C. (1992): Mendelian inheritance of familial prostate cancer, Proc.Natl.Acad.Sci.U.S.A 89 [8], Page 3367-3371.

Caterina, M. J.; Rosen, T. A.; Tominaga, M.; Brake, A. J. und Julius, D. (1999): A capsaicin-receptor homologue with a high threshold for noxious heat, Nature 398 [6726], Page 436-441.

Caterina, M. J.; Schumacher, M. A.; Tominaga, M.; Rosen, T. A.; Levine, J. D. und Julius, D. (1997): The capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature 389 [6653], Page 816-824.

Chang, C. H.; Sharkey, R. M.; Rossi, E. A.; Karacay, H.; McBride, W.; Hansen, H. J.; Chatal, J. F.; Barbet, J. und Goldenberg, D. M. (2002): Molecular advances in pretargeting radioimunotherapy with bispecific antibodies, Mol.Cancer Ther. 1 [7], Page 553-563.

Charlet, B.; Logan, P.; Singh, G. und Cooper, T. A. (2002): Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing, Mol.Cell 9 [3], Page 649-658.

Chow, L. T.; Gelinas, R. E.; Broker, T. R. und Roberts, R. J. (1977): An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA, Cell 12 [1], Page 1-8.

Chyb, S.; Raghu, P. und Hardie, R. C. (1999): Polyunsaturated fatty acids activate the Drosophila light-sensitive channels TRP and TRPL, Nature 397 [6716], Page 255-259.

Clapham, D. E.; Runnels, L. W. und Strubing, C. (2001): The TRP ion channel family, Nat.Rev.Neurosci. 2 [6], Page 387-396.

Cleutjens, K. B.; van Eekelen, C. C.; van der Korput, H. A.; Brinkmann, A. O. und Trapman, J. (1996): Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter, J.Biol.Chem. 271 [11], Page 6379-6388.

Debes, J. D. und Tindall, D. J. (2002): The role of androgens and the androgen receptor in prostate cancer, Cancer Lett. 187 [1-2], Page 1-7.

den Dekker, E.; Hoenderop, J. G.; Nilius, B. und Bindels, R. J. (2003): The epithelial calcium channels, TRPV5 & TRPV6: from identification towards regulation, Cell Calcium 33 [5-6], Page 497-507.

Dhanasekaran, S. M.; Barrette, T. R.; Ghosh, D.; Shah, R.; Varambally, S.; Kurachi, K.; Pienta, K. J.; Rubin, M. A. und Chinnaiyan, A. M. (2001): Delineation of prognostic biomarkers in prostate cancer, Nature 412 [6849], Page 822-826.

Duncan, L. M.; Deeds, J.; Hunter, J.; Shao, J.; Holmgren, L. M.; Woolf, E. A.; Tepper, R. I. und Shyjan, A. W. (1998): Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis, Cancer Res. 58 [7], Page 1515-1520.

Emerson, B. M. (2002): Specificity of gene regulation, Cell 109 [3], Page 267-270.

Faustino, N. A. und Cooper, T. A. (2003): Pre-mRNA splicing and human disease, Genes Dev. 17 [4], Page 419-437.

Fu, X. D. (1995): The superfamily of arginine/serine-rich splicing factors, RNA. 1 [7], Page 663-680.

Gandini, O.; Luci, L.; Stigliano, A.; Lucera, R.; Di Silverio, F.; Toscano, V. und Cardillo, M. R. (2003): Is DD3 a new prostate-specific gene?, Anticancer Res. 23 [1A], Page 305-308.

Gleason, D. F. und Mellinger, G. T. (1974): Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging, J.Urol. 111 [1], Page 58-64.

Graveley, B. R. (2000): Sorting out the complexity of SR protein functions, RNA. 6 [9], Page 1197-1211.

Gregory, C. W.; Hamil, K. G.; Kim, D.; Hall, S. H.; Pretlow, T. G.; Mohler, J. L. und French, F. S. (1998): Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes, Cancer Res. 58 [24], Page 5718-5724.

Grimm, C.; Kraft, R.; Sauerbruch, S.; Schultz, G. und Harteneck, C. (2003): Molecular and functional characterization of the melastatin-related cation channel TRPM3, J.Biol.Chem. 278 [24], Page 21493-21501.

Grynkiewicz, G.; Poenie, M. und Tsien, R. Y. (1985): A new generation of Ca2+ indicators with greatly improved fluorescence properties, J.Biol.Chem. 260 [6], Page 3440-3450.

Guler, A. D.; Lee, H.; Iida, T.; Shimizu, I.; Tominaga, M. und Caterina, M. (2002): Heat-evoked activation of the ion channel, TRPV4, J.Neurosci. 22 [15], Page 6408-6414.

Hardie, R. C. und Minke, B. (1992): The trp gene is essential for a light-activated Ca2+ channel in Drosophila photoreceptors, Neuron 8 [4], Page 643-651.

He, W. W.; Sciavolino, P. J.; Wing, J.; Augustus, M.; Hudson, P.; Meissner, P. S.; Curtis, R. T.; Shell, B. K.; Bostwick, D. G.; Tindall, D. J.; Gelmann, E. P.; Abate-Shen, C. und Carter, K. C. (1997): A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer, Genomics 43 [1], Page 69-77.

Henshall, S. M.; Afar, D. E.; Hiller, J.; Horvath, L. G.; Quinn, D. I.; Rasiah, K. K.; Gish, K.; Willhite, D.; Kench, J. G.; Gardiner-Garden, M.; Stricker, P. D.; Scher, H. I.; Grygiel, J. J.; Agus, D. B.; Mack, D. H. und Sutherland, R. L. (2003): Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse, Cancer Res. 63 [14], Page 4196-4203.

Hofmann, T.; Obukhov, A. G.; Schaefer, M.; Harteneck, C.; Gudermann, T. und Schultz, G. (1999): Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol, Nature 397 [6716], Page 259-263.

Howe, H. L.; Wingo, P. A.; Thun, M. J.; Ries, L. A.; Rosenberg, H. M.; Feigal, E. G. und Edwards, B. K. (2001): Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends, J.Natl.Cancer Inst. 93 [11], Page 824-842.

Huang, H. und Tindall, D. J. (2002): The role of the androgen receptor in prostate cancer, Crit Rev.Eukaryot.Gene Expr. 12 [3], Page 193-207.

Hudson, P. (1981): Robust Statistics.

Huggins, C. und Hodges, C. V. (2002): Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941, J.Urol. 167 [2 Pt 2], Page 948-951.

Jemal, A.; Murray, T.; Samuels, A.; Ghafoor, A.; Ward, E. und Thun, M. J. (2003): Cancer statistics, 2003, CA Cancer J.Clin. 53 [1], Page 5-26.

Kieschke, J.; Lehnert, M.; Oberhausen, R.; Schmidtmann, I. und Schneider, D. (2002): Krebs in Deutschland- Häufigkeiten und Trends. URL: http://www.rki.de/KREBS

Kraft, R.; Grimm, C.; Grosse, K.; Hoffmann, A.; Sauerbruch, S.; Kettenmann, H.; Schultz, G. und Harteneck, C. (2004): Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia, Am.J.Physiol Cell Physiol 286 [1], Page C129-C137.

Kristal, A. R.; Cohen, J. H.; Qu, P. und Stanford, J. L. (2002): Associations of energy, fat, calcium, and vitamin D with prostate cancer risk, Cancer Epidemiol.Biomarkers Prev. 11 [8], Page 719-725.

Lander, E. S.; Linton, L. M.; Birren, B.; Nusbaum, C.; Zody, M. C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W.; Funke, R.; Gage, D.; Harris, K.; Heaford, A.; Howland, J.; Kann, L.; Lehoczky, J.; LeVine, R.; McEwan, P.; McKernan, K.; Meldrim, J.; Mesirov, J. P.; Miranda, C.; Morris, W.; Naylor, J.; Raymond, C.; Rosetti, M.; Santos, R.; Sheridan, A.; Sougnez, C.; Stange-Thomann, N.; Stojanovic, N.; Subramanian, A.; Wyman, D.; Rogers, J.; Sulston, J.; Ainscough, R.; Beck, S.; Bentley, D.; Burton, J.; Clee, C.; Carter, N.; Coulson, A.; Deadman, R.; Deloukas, P.; Dunham, A.; Dunham, I.; Durbin, R.; French, L.; Grafham, D.; Gregory, S.; Hubbard, T.; Humphray, S.; Hunt, A.; Jones, M.; Lloyd, C.; McMurray, A.; Matthews, L.; Mercer, S.; Milne, S.; Mullikin, J. C.; Mungall, A.; Plumb, R.; Ross, M.; Shownkeen, R.; Sims, S.; Waterston, R. H.; Wilson, R. K.; Hillier, L. W.; McPherson, J. D.; Marra, M. A.; Mardis, E. R.; Fulton, L. A.; Chinwalla, A. T.; Pepin, K. H.; Gish, W. R.; Chissoe, S. L.; Wendl, M. C.; Delehaunty, K. D.; Miner, T. L.; Delehaunty, A.; Kramer, J. B.; Cook, L. L.; Fulton, R. S.; Johnson, D. L.; Minx, P. J.; Clifton, S. W.; Hawkins, T.; Branscomb, E.; Predki, P.; Richardson, P.; Wenning, S.; Slezak, T.; Doggett, N.; Cheng, J. F.; Olsen, A.; Lucas, S.; Elkin, C.; Uberbacher, E.; Frazier, M.; Gibbs, R. A.; Muzny, D. M.; Scherer, S. E.; Bouck, J. B.; Sodergren, E. J.; Worley, K. C.; Rives, C. M.; Gorrell, J. H.; Metzker, M. L.; Naylor, S. L.; Kucherlapati, R. S.; Nelson, D. L.; Weinstock, G. M.; Sakaki, Y.; Fujiyama, A.; Hattori, M.; Yada, T.; Toyoda, A.; Itoh, T.; Kawagoe, C.; Watanabe, H.; Totoki, Y.; Taylor, T.; Weissenbach, J.; Heilig, R.; Saurin, W.; Artiguenave, F.; Brottier, P.; Bruls, T.; Pelletier, E.; Robert, C.; Wincker, P.; Smith, D. R.; Doucette-Stamm, L.; Rubenfield, M.; Weinstock, K.; Lee, H. M.; Dubois, J.; Rosenthal, A.; Platzer, M.; Nyakatura, G.; Taudien, S.; Rump, A.; Yang, H.; Yu, J.; Wang, J.; Huang, G.; Gu, J.; Hood, L.; Rowen, L.; Madan, A.; Qin, S.; Davis, R. W.; Federspiel, N. A.; Abola, A. P.; Proctor, M. J.; Myers, R. M.; Schmutz, J.; Dickson, M.; Grimwood, J.; Cox, D. R.; Olson, M. V.; Kaul, R.; Raymond, C.; Shimizu, N.; Kawasaki, K.; Minoshima, S.; Evans, G. A.; Athanasiou, M.; Schultz, R.; Roe, B. A.; Chen, F.; Pan, H.; Ramser, J.; Lehrach, H.; Reinhardt, R.; McCombie, W. R.; de la, Bastide M.; Dedhia, N.; Blocker, H.; Hornischer, K.; Nordsiek, G.; Agarwala, R.; Aravind, L.; Bailey, J. A.; Bateman, A.; Batzoglou, S.; Birney, E.; Bork, P.; Brown, D. G.; Burge, C. B.; Cerutti, L.; Chen, H. C.; Church, D.; Clamp, M.; Copley, R. R.; Doerks, T.; Eddy, S. R.; Eichler, E. E.; Furey, T. S.; Galagan, J.; Gilbert, J. G.; Harmon, C.; Hayashizaki, Y.; Haussler, D.; Hermjakob, H.; Hokamp, K.; Jang, W.; Johnson, L. S.; Jones, T. A.; Kasif, S.; Kaspryzk, A.; Kennedy, S.; Kent, W. J.; Kitts, P.; Koonin, E. V.; Korf, I.; Kulp, D.; Lancet, D.; Lowe, T. M.; McLysaght, A.; Mikkelsen, T.; Moran, J. V.; Mulder, N.; Pollara, V. J.; Ponting, C. P.; Schuler, G.; Schultz, J.; Slater, G.; Smit, A. F.; Stupka, E.; Szustakowski, J.; Thierry-Mieg, D.; Thierry-Mieg, J.; Wagner, L.; Wallis, J.; Wheeler, R.; Williams, A.; Wolf, Y. I.; Wolfe, K. H.; Yang, S. P.; Yeh, R. F.; Collins, F.; Guyer, M. S.; Peterson, J.; Felsenfeld, A.; Wetterstrand, K. A.; Patrinos, A.; Morgan, M. J.; Szustakowki, J.; de Jong, P.; Catanese, J. J.; Osoegawa, K.; Shizuya, H. und Choi, S. (2001): Initial sequencing and analysis of the human genome, Nature 409 [6822], Page 860-921.

Laufer, M.; Denmeade, S. R.; Sinibaldi, V. J.; Carducci, M. A. und Eisenberger, M. A. (2000): Complete androgen blockade for prostate cancer: what went wrong?, J.Urol. 164 [1], Page 3-9.

Launay, P.; Fleig, A.; Perraud, A. L.; Scharenberg, A. M.; Penner, R. und Kinet, J. P. (2002): TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization, Cell 109 [3], Page 397-407.

Lee, H. J. und Chang, C. (2003): Recent advances in androgen receptor action, Cell Mol.Life Sci. 60 [8], Page 1613-1622.

Lichter, P.; Bentz, M. und Joos, S. (1995): Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization, Methods Enzymol. 254, Page 334-359.

Lo, M. V. und Pak, W. L. (1981): Light-induced pigment granule migration in the retinular cells of Drosophila melanogaster. Comparison of wild type with ERG-defective mutants, J.Gen.Physiol 77 [2], Page 155-175.

Luo, J.; Duggan, D. J.; Chen, Y.; Sauvageot, J.; Ewing, C. M.; Bittner, M. L.; Trent, J. M. und Isaacs, W. B. (2001): Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling, Cancer Res. 61 [12], Page 4683-4688.

Luo, L.; Salunga, R. C.; Guo, H.; Bittner, A.; Joy, K. C.; Galindo, J. E.; Xiao, H.; Rogers, K. E.; Wan, J. S.; Jackson, M. R. und Erlander, M. G. (1999): Gene expression profiles of laser-captured adjacent neuronal subtypes, Nat.Med. 5 [1], Page 117-122.

Macintosh, C. A.; Stower, M.; Reid, N. und Maitland, N. J. (1998): Precise microdissection of human prostate cancers reveals genotypic heterogeneity, Cancer Res. 58 [1], Page 23-28.

Macoska, J. A.; Trybus, T. M.; Benson, P. D.; Sakr, W. A.; Grignon, D. J.; Wojno, K. D.; Pietruk, T. und Powell, I. J. (1995): Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer, Cancer Res. 55 [22], Page 5390-5395.

Magee, J. A.; Araki, T.; Patil, S.; Ehrig, T.; True, L.; Humphrey, P. A.; Catalona, W. J.; Watson, M. A. und Milbrandt, J. (2001): Expression profiling reveals hepsin overexpression in prostate cancer, Cancer Res. 61 [15], Page 5692-5696.

McKemy, D. D.; Neuhausser, W. M. und Julius, D. (2002): Identification of a cold receptor reveals a general role for TRP channels in thermosensation, Nature 416 [6876], Page 52-58.

Mercatante, D. R. und Kole, R. (2002): Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression, Biochim.Biophys.Acta 1587 [2-3], Page 126-132.

Modrek, B. und Lee, C. (2002): A genomic view of alternative splicing, Nat.Genet. 30 [1], Page 13-19.

Montell, C. (1997): New light on TRP and TRPL, Mol.Pharmacol. 52 [5], Page 755-763.

Montell, C.; Birnbaumer, L. und Flockerzi, V. (2002): The TRP channels, a remarkably functional family, Cell 108 [5], Page 595-598.

Nakada, S. Y.; di Sant'Agnese, P. A.; Moynes, R. A.; Hiipakka, R. A.; Liao, S.; Cockett, A. T. und Abrahamsson, P. A. (1993): The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue, Cancer Res. 53 [9], Page 1967-1970.

Nilius, B. (2003): From TRPs to SOCs, CCEs, and CRACs: consensus and controversies, Cell Calcium 33 [5-6], Page 293-298.

Nilius, B.; Prenen, J.; Droogmans, G.; Voets, T.; Vennekens, R.; Freichel, M.; Wissenbach, U. und Flockerzi, V. (2003): Voltage dependence of the Ca2+-activated cation channel TRPM4, J.Biol.Chem. 278 [33], Page 30813-30820.

Nissim-Rafinia, M. und Kerem, B. (2002): Splicing regulation as a potential genetic modifier, Trends Genet. 18 [3], Page 123-127.

Nowell, P. C. (1997): Genetic alterations in leukemias and lymphomas: impressive progress and continuing complexity, Cancer Genet.Cytogenet. 94 [1], Page 13-19.

Nunes, F. D.; de Almeida, F. C.; Tucci, R. und de Sousa, S. C. (2003): Homeobox genes: a molecular link between development and cancer, Pesqui.Odontol.Bras. 17 [1], Page 94-98.

Peier, A. M.; Moqrich, A.; Hergarden, A. C.; Reeve, A. J.; Andersson, D. A.; Story, G. M.; Earley, T. J.; Dragoni, I.; McIntyre, P.; Bevan, S. und Patapoutian, A. (2002): A TRP channel that senses cold stimuli and menthol, Cell 108 [5], Page 705-715.

Perez, C. A.; Huang, L.; Rong, M.; Kozak, J. A.; Preuss, A. K.; Zhang, H.; Max, M. und Margolskee, R. F. (2002): A transient receptor potential channel expressed in taste receptor cells, Nat.Neurosci. 5 [11], Page 1169-1176.

Perraud, A. L.; Fleig, A.; Dunn, C. A.; Bagley, L. A.; Launay, P.; Schmitz, C.; Stokes, A. J.; Zhu, Q.; Bessman, M. J.; Penner, R.; Kinet, J. P. und Scharenberg, A. M. (2001): ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology, Nature 411 [6837], Page 595-599.

Philips, A. V. und Cooper, T. A. (2000): RNA processing and human disease, Cell Mol.Life Sci. 57 [2], Page 235-249.

Pilarsky, C., Kristiansen, G., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepke, S., Hoffmann, P., Staub, E., Dahl, E., Hinzmann, B., Specht, T., Stephan, C., Jung, K., Loening, S., Bellach, J., Dietel, M., and Rosenthal, A. (2003): Expression Profiling of Microdissected matched Prostate Cancer Samples Reveals New Prognostic Markers for Patient Survival

Prawitt, D.; Enklaar, T.; Klemm, G.; Gartner, B.; Spangenberg, C.; Winterpacht, A.; Higgins, M.; Pelletier, J. und Zabel, B. (2000): Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression, Hum.Mol.Genet. 9 [2], Page 203-216.

Putney, J. W., Jr. (1997): Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry, Cell Calcium 21 [3], Page 257-261.

Putney, J. W., Jr. und McKay, R. R. (1999): Capacitative calcium entry channels, Bioessays 21 [1], Page 38-46.

Quandt, K.; Frech, K.; Karas, H.; Wingender, E. und Werner, T. (1995): MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data, Nucleic Acids Res. 23 [23], Page 4878-4884.

Rhodes, D. R.; Barrette, T. R.; Rubin, M. A.; Ghosh, D. und Chinnaiyan, A. M. (2002): Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer, Cancer Res. 62 [15], Page 4427-4433.

Riegman, P. H.; Vlietstra, R. J.; van der Korput, J. A.; Brinkmann, A. O. und Trapman, J. (1991): The promoter of the prostate-specific antigen gene contains a functional androgen responsive element, Mol.Endocrinol. 5 [12], Page 1921-1930.

Runnels, L. W.; Yue, L. und Clapham, D. E. (2001): TRP-PLIK, a bifunctional protein with kinase and ion channel activities, Science 291 [5506], Page 1043-1047.

Sadar, M. D.; Hussain, M. und Bruchovsky, N. (1999): Prostate cancer: molecular biology of early progression to androgen independence, Endocr.Relat Cancer 6 [4], Page 487-502.

Sanger, F.; Nicklen, S. und Coulson, A. R. (1977): DNA sequencing with chain-terminating inhibitors, Proc.Natl.Acad.Sci.U.S.A 74 [12], Page 5463-5467.

Sauvageot, J. und Epstein, J. I. (1998): Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy, Prostate 34 [1], Page 29-33.

Schaefer, M.; Plant, T. D.; Stresow, N.; Albrecht, N. und Schultz, G. (2002): Functional differences between TRPC4 splice variants, J.Biol.Chem. 277 [5], Page 3752-3759.

Schena, M.; Shalon, D.; Davis, R. W. und Brown, P. O. (1995): Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science 270 [5235], Page 467-470.

Schlingmann, K. P.; Weber, S.; Peters, M.; Niemann, Nejsum L.; Vitzthum, H.; Klingel, K.; Kratz, M.; Haddad, E.; Ristoff, E.; Dinour, D.; Syrrou, M.; Nielsen, S.; Sassen, M.; Waldegger, S.; Seyberth, H. W. und Konrad, M. (2002): Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family, Nat.Genet. 31 [2], Page 166-170.

Schmitt, A. O.; Specht, T.; Beckmann, G.; Dahl, E.; Pilarsky, C. P.; Hinzmann, B. und Rosenthal, A. (1999): Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues, Nucleic Acids Res. 27 [21], Page 4251-4260.

Seemann, G.; Bosslet, K. und Sedlacek, H. H. (1990): Recombinant monoclonal antibodies in tumor therapy, Behring Inst.Mitt. [87], Page 33-47.

Silberstein, G. B.; Dressler, G. R. und Van Horn, K. (2002): Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth, Oncogene 21 [7], Page 1009-1016.

Singh, D.; Febbo, P. G.; Ross, K.; Jackson, D. G.; Manola, J.; Ladd, C.; Tamayo, P.; Renshaw, A. A.; D'Amico, A. V.; Richie, J. P.; Lander, E. S.; Loda, M.; Kantoff, P. W.; Golub, T. R. und Sellers, W. R. (2002): Gene expression correlates of clinical prostate cancer behavior, Cancer Cell 1 [2], Page 203-209.

Smith, G. D.; Gunthorpe, M. J.; Kelsell, R. E.; Hayes, P. D.; Reilly, P.; Facer, P.; Wright, J. E.; Jerman, J. C.; Walhin, J. P.; Ooi, L.; Egerton, J.; Charles, K. J.; Smart, D.; Randall, A. D.; Anand, P. und Davis, J. B. (2002): TRPV3 is a temperature-sensitive vanilloid receptor-like protein, Nature 418 [6894], Page 186-190.

Smith, J. R.; Freije, D.; Carpten, J. D.; Gronberg, H.; Xu, J.; Isaacs, S. D.; Brownstein, M. J.; Bova, G. S.; Guo, H.; Bujnovszky, P.; Nusskern, D. R.; Damber, J. E.; Bergh, A.; Emanuelsson, M.; Kallioniemi, O. P.; Walker-Daniels, J.; Bailey-Wilson, J. E.; Beaty, T. H.; Meyers, D. A.; Walsh, P. C.; Collins, F. S.; Trent, J. M. und Isaacs, W. B. (1996): Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search, Science 274 [5291], Page 1371-1374.

So, A. I.; Hurtado-Coll, A. und Gleave, M. E. (2003): Androgens and prostate cancer, World J.Urol..

Steadman, D. J.; Giuffrida, D. und Gelmann, E. P. (2000): DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1, Nucleic Acids Res. 28 [12], Page 2389-2395.

Stickeler, E.; Kittrell, F.; Medina, D. und Berget, S. M. (1999): Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis, Oncogene 18 [24], Page 3574-3582.

Stockwin, L. und Holmes, S. (2003): Antibodies as therapeutic agents: vive la renaissance!, Expert.Opin.Biol.Ther. 3 [7], Page 1133-1152.

Story, G. M.; Peier, A. M.; Reeve, A. J.; Eid, S. R.; Mosbacher, J.; Hricik, T. R.; Earley, T. J.; Hergarden, A. C.; Andersson, D. A.; Hwang, S. W.; McIntyre, P.; Jegla, T.; Bevan, S. und Patapoutian, A. (2003): ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures, Cell 112 [6], Page 819-829.

Strubing, C.; Krapivinsky, G.; Krapivinsky, L. und Clapham, D. E. (2001): TRPC1 and TRPC5 form a novel cation channel in mammalian brain, Neuron 29 [3], Page 645-655.

Suzuki, H.; Ueda, T.; Ichikawa, T. und Ito, H. (2003): Androgen receptor involvement in the progression of prostate cancer, Endocr.Relat Cancer 10 [2], Page 209-216.

Tsavaler, L.; Shapero, M. H.; Morkowski, S. und Laus, R. (2001): Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins, Cancer Res. 61 [9], Page 3760-3769.

Vocke, C. D.; Pozzatti, R. O.; Bostwick, D. G.; Florence, C. D.; Jennings, S. B.; Strup, S. E.; Duray, P. H.; Liotta, L. A.; Emmert-Buck, M. R. und Linehan, W. M. (1996): Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21, Cancer Res. 56 [10], Page 2411-2416.

von Bubnoff, N.; Veach, D. R.; Miller, W. T.; Li, W.; Sanger, J.; Peschel, C.; Bornmann, W. G.; Clarkson, B. und Duyster, J. (2003): Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors, Cancer Res. 63 [19], Page 6395-6404.

Walder, R. Y.; Landau, D.; Meyer, P.; Shalev, H.; Tsolia, M.; Borochowitz, Z.; Boettger, M. B.; Beck, G. E.; Englehardt, R. K.; Carmi, R. und Sheffield, V. C. (2002): Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia, Nat.Genet. 31 [2], Page 171-174.

Warren D.W. and Heston : PSMA Promoter/Enhancer: Tools for Potential Gene Therapy Approaches. URL: http://www.clevelandclinic.org/urology/news/lab/vol8u.htm

Wehage, E.; Eisfeld, J.; Heiner, I.; Jungling, E.; Zitt, C. und Luckhoff, A. (2002): Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose, J.Biol.Chem. 277 [26], Page 23150-23156.

Welsh, J. B.; Sapinoso, L. M.; Su, A. I.; Kern, S. G.; Wang-Rodriguez, J.; Moskaluk, C. A.; Frierson, H. F., Jr. und Hampton, G. M. (2001): Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer, Cancer Res. 61 [16], Page 5974-5978.

Werner, T.; Fessele, S.; Maier, H. und Nelson, P. J. (2003): Computer modeling of promoter organization as a tool to study transcriptional coregulation, FASEB J. 17 [10], Page 1228-1237.

Wilcoxon, F (1945):

Wissmann, C. (2002): Identifizierung differentiell exprimierter Gene in Tumoren der Prostata und Harnblase, metaGen.

Xu, H.; Ramsey, I. S.; Kotecha, S. A.; Moran, M. M.; Chong, J. A.; Lawson, D.; Ge, P.; Lilly, J.; Silos-Santiago, I.; Xie, Y.; DiStefano, P. S.; Curtis, R. und Clapham, D. E. (2002): TRPV3 is a calcium-permeable temperature-sensitive cation channel, Nature 418 [6894], Page 181-186.

Xu, J.; Meyers, D.; Freije, D.; Isaacs, S.; Wiley, K.; Nusskern, D.; Ewing, C.; Wilkens, E.; Bujnovszky, P.; Bova, G. S.; Walsh, P.; Isaacs, W.; Schleutker, J.; Matikainen, M.; Tammela, T.; Visakorpi, T.; Kallioniemi, O. P.; Berry, R.; Schaid, D.; French, A.; McDonnell, S.; Schroeder, J.; Blute, M.; Thibodeau, S.; Trent, J. und . (1998): Evidence for a prostate cancer susceptibility locus on the X chromosome, Nat.Genet. 20 [2], Page 175-179.

Xu, X. Z.; Moebius, F.; Gill, D. L. und Montell, C. (2001): Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform, Proc.Natl.Acad.Sci.U.S.A 98 [19], Page 10692-10697.

Zahler, A. M.; Lane, W. S.; Stolk, J. A. und Roth, M. B. (1992): SR proteins: a conserved family of pre-mRNA splicing factors, Genes Dev. 6 [5], Page 837-847.

Zhang, W.; Chu, X.; Tong, Q.; Cheung, J. Y.; Conrad, K.; Masker, K. und Miller, B. A. (2003): A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death, J.Biol.Chem. 278 [18], Page 16222-16229.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: